Tikcro Technologies Ltd. (TIKRF)
Tikcro Technologies Ltd. operates in the Shell Companies industry of the Financial Services sector, headquartered in Hadera, IL. The stock last traded at $0.11, up 0.00% on the session, giving a market capitalisation of $1.1M. On trailing twelve-month figures it carries a trailing P/E of -2.27, a net margin of 0.0%. Its beta of -1.76 implies it has historically moved less than the broad market.
Tikcro Technologies Ltd., an Israeli enterprise, is primarily involved in advancing biotechnology projects. Among its offerings is anti-cytotoxic T-lymphocyte-associated protein 4, which is utilized for immunotherapeutic approaches to cancer. The company, established in 1999, was previously known as Tioga Technologies Ltd. before rebranding to its current name in September 2003. Its main office is located in Hadera, Israel.
Tikcro Technologies Ltd. is most often compared with the following Financial Services names: